LLY logo

Eli Lilly and Company (LLY)

Profile

Full Name

Eli Lilly and Company

Ticker Symbol

LLY

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

June 1, 1972

Indexes

S&P 500

Website

http://www.lilly.com

Employees

47000

Key Details

Price

$726.24(+0.35%)

Market cap

$652.29B(Mega cap)

Last Dividend

$1.50

TTM Dividend yield

0.74%

Annual revenue

$45.04B(+32.00% YoY)

Annual EPS

$11.71(+101.90% YoY)

PE ratio

62.02

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$726.24
LLY price is $726.24

30-Day Relative Volume

1.15
LLY 30-day relative volume is 1.15

Price Performance

Price Most recent change

+0.35%
LLY price was up +0.35% on Apr 8, 2025

Price YTD change

-5.93%
LLY price is down -5.93% since January 1st

Price 1-year change

-4.09%
LLY price is down -4.09% year-on-year

Price 3-year change

+133%
LLY price is up +133% over the past 3 years

Price Range

Price All-time high

$972.53
LLY price is currently -25.32% below its historical high of $972.53

Price 3-year low

$276.83
LLY price is currently +162.34% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$652.29B
LLY market capitalization is $652.29 billion

Market cap 3-year change

+120.15%
LLY market capitalization is up +120.15% over the past 3 years

Market cap All-time high

$864.41B
LLY market capitalization is currently -24.54% below its historical high of $864.41 billion

Market cap sector rank

100%
LLY market capitalization is higher than 100% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.25%
LLY shares outstanding is down -0.25% year-on-year

Shares Outstanding 3-Year Change

-5.52%
LLY shares outstanding is down -5.52% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
LLY beta is 0.79

200-day SMA

$852.26
LLY price is currently -14.79% below its 200-day simple moving average

50-day SMA

$844.23
LLY price is currently -13.98% below its 50-day simple moving average

RSI

28.18
LLY 14-day relative strength index is 28.18

Volume

1.15
LLY 30-day relative volume is 1.15

ATR

$33.18
LLY average true range is $33.18

10-day Historical Volatility

38.25%
LLY 10-day historical volatility is 38.25%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.50
LLY last dividend was $1.50 per share, with an ex-dividend date of February 14, 2025

Next Dividend

-
LLY next dividend has not yet been announced

Dividend per share

Dividend per share

$5.20
LLY annual dividend per share is $5.20

Dividend per share Sector Rank

91.86%
LLY annual dividend per share is higher than 91.86% of companies in Healthcare sector

Dividend per share 1-Year Change

+15.04%
LLY annual dividend per share is up +15.04% year-on-year

Dividend per share 3-Year Change

+52.94%
LLY annual dividend per share is up +52.94% over the past 3 years

Dividend yield

Dividend yield

0.72%
LLY annual dividend yield is 0.72%

Dividend yield Sector Rank

18.82%
LLY annual dividend yield is higher than 18.82% of companies in Healthcare sector

Other

Payout ratio

44.20%
LLY annual payout ratio is 44.20%

Dividends paid

$4.68B
LLY annual dividends paid is $4.68 billion

Free cash flow

$414.30M
LLY annual free cash flow is $414.30 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$45.04B
LLY annual revenue is $45.04 billion

Revenue Analysts estimate

$59.40B
LLY annual revenue is currently -24.17% lower than the consensus analysts' forecast

Revenue 1-year change

+32%
LLY annual revenue is up +32% year-on-year

Revenue Sector rank

97.87%
LLY annual revenue is higher than 97.87% of companies in Healthcare sector

EPS

EPS

$11.71
LLY annual earnings per share is $11.71

EPS Analysts estimate

$23.19
LLY annual earnings per share is currently -49.51% lower than the consensus analysts' forecast

EPS 1-year change

+101.9%
LLY annual earnings per share is up +101.9% year-on-year

EPS Sector rank

98.51%
LLY annual earnings per share is higher than 98.51% of companies in Healthcare sector

Profit

Gross profit

$36.62B
LLY annual gross profit is $36.62 billion

Gross margin

81.31%
LLY annual gross profit margin is 81.31%

Operating profit

$17.04B
LLY annual operating income is $17.04 billion

Operating margin

37.83%
LLY annual operating profit margin is 37.83%

Net income

$10.59B
LLY annual net profit is $10.59 billion

Net margin

23.51%
LLY annual net profit margin is 23.51%

Expenses

Total expenses

$28.00B
LLY annual total expenses is $28.00 billion

Operating expenses

$19.58B
LLY annual total operating expenses is $19.58 billion

Cost of goods sold

$8.42B
LLY annual cost of goods sold is $8.42 billion

Selling, general & administrative expenses

$8.59B
LLY annual SGA is $8.59 billion

Depreciation and amortization

$1.77B
LLY annual depreciation & amortization is $1.77 billion

Interest expense

$780.60M
LLY annual interest expense is $780.60 million

Income tax

$2.09B
LLY annual income tax is $2.09 billion

EBIT & EBITDA

EBIT

$17.04B
LLY annual earnings before interest & taxes is $17.04 billion

EBITDA

$17.04B
LLY annual EBITDA is $17.04 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$78.71B
LLY annual total assets is $78.71 billion

Non current assets

$45.98B
LLY annual long term assets is $45.98 billion

Current assets

$32.74B
LLY annual total current assets is $32.74 billion

Cash and cash equivalents

$3.27B
LLY annual cash & cash equivalents is $3.27 billion

Accounts receivable

$11.01B
LLY annual accounts receivable is $11.01 billion

Inventory

$7.59B
LLY annual inventory is $7.59 billion

Liabilities

Total liabilities

$64.44B
LLY annual total liabilities is $64.44 billion

Long term liabilities

$36.07B
LLY annual total long term liabilities is $36.07 billion

Current liabilities

$28.38B
LLY annual total current liabilities is $28.38 billion

Accounts payable

$3.23B
LLY annual accounts payable is $3.23 billion

Debt

Total debt

$33.64B
LLY annual total debt is $33.64 billion

Total debt 1-year change

+33.37%
LLY annual total debt is up +33.37% year-on-year

Long term debt

$28.53B
LLY annual long term debt is $28.53 billion

Short term debt

$5.12B
LLY annual short term debt is $5.12 billion

Equity & Capital

Shareholders equity

$14.19B
LLY annual stockholders equity is $14.19 billion

Book value

$14.19B
LLY annual book value is $14.19 billion

Retained earnings

$13.54B
LLY annual retained earnings is $13.54 billion

Working capital

$4.36B
LLY annual working capital is $4.36 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$8.82B
LLY annual cash flow from operations is $8.82 billion

Cash from operations 1-year change

+107.96%
LLY annual cash flow from operations is up +107.96% year-on-year

Cash from investing

-$9.30B
LLY annual cash flow from investing activities is -$9.30 billion

Cash from investing 1-year change

-30.04%
LLY annual cash flow from investing activities is down -30.04% year-on-year

Cash from financing

$1.23B
LLY annual cash flow from financing activities is $1.23 billion

Cash from financing 1-year change

-64.81%
LLY annual cash flow from financing activities is down -64.81% year-on-year

CAPEX

CAPEX

$8.40B
LLY annual capital expenditures is $8.40 billion

CAPEX 1-year change

+13.68%
LLY annual capital expenditures is up +13.68% year-on-year

Free Cash Flow

Free cash flow

$414.30M
LLY annual free cash flow is $414.30 million

Free cash flow 1-year change

+113.14%
LLY annual free cash flow is up +113.14% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

81.31%
LLY annual gross profit margin is 81.31%

Operating margin

37.83%
LLY annual operating profit margin is 37.83%

Net margin

23.51%
LLY annual net profit margin is 23.51%

ROA & ROE

ROA

14.84%
LLY annual return on assets is 14.84%

ROE

84.26%
LLY annual return on equity is 84.26%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

62.02
LLY price to earnings ratio is 62.02

PE ratio Sector rank

83.82%
LLY price to earnings ratio is higher than 83.82% of companies in Healthcare sector

PB Ratio

PB ratio

45.96
LLY price to book ratio is 45.96

PB ratio Sector rank

98.77%
LLY price to book ratio is higher than 98.77% of companies in Healthcare sector

PS Ratio

PS ratio

14.48
LLY price to sales ratio is 14.48

PS ratio Sector rank

84.49%
LLY price to sales ratio is higher than 84.49% of companies in Healthcare sector

Enterprise value

Enterprise value

$682.66B
LLY enterprise value is $682.66 billion

Enterprise value Sector rank

100%
LLY enterprise value is higher than 100% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

45.03
LLY EV/EBITDA is 45.03

EV/EBITDA Sector rank

96.96%
LLY EV/EBITDA is higher than 96.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.15
LLY annual current ratio is 1.15

Quick ratio

0.89
LLY annual quick ratio is 0.89

Leverage

Debt to equity

2.37
LLY annual debt to equity ratio is 2.37

Interest coverage ratio

21.83
LLY annual interest coverage ratio is 21.83

Risk & Stability

Piotroski F-Score

7
LLY piotroski f-score is 7

Altman Z-Score

7.67
LLY altman z-score is 7.67

Analyst ratings

Recent major analysts updates

Mar 5, 25 Wells Fargo
Overweight
Feb 3, 25 Truist Securities
Buy
Jan 28, 25 Wells Fargo
Overweight
Jan 28, 25 Citigroup
Buy
Nov 15, 24 Wolfe Research
Outperform
Nov 4, 24 Deutsche Bank
Buy
Oct 31, 24 Barclays
Overweight
Oct 31, 24 B of A Securities
Buy
Oct 25, 24 Citigroup
Buy
Oct 17, 24 Bernstein
Outperform

Institutional Ownership

Similar stocks

UNH logo
UnitedHealth Group Incorporated (UNH)
JNJ logo
Johnson & Johnson (JNJ)
ABBV logo
AbbVie (ABBV)
NVO logo
Novo Nordisk A/S (NVO)
ABT logo
Abbott Laboratories (ABT)
NVS logo
Novartis AG (NVS)
AZN logo
AstraZeneca (AZN)
MRK logo
Merck & Co (MRK)
ISRG logo
Intuitive Surgical (ISRG)
  • What is the ticker symbol for Eli Lilly and Company?
  • Does Eli Lilly and Company pay dividends?
  • What sector is Eli Lilly and Company in?
  • What industry is Eli Lilly and Company in?
  • What country is Eli Lilly and Company based in?
  • When did Eli Lilly and Company go public?
  • Is Eli Lilly and Company in the S&P 500?
  • Is Eli Lilly and Company in the NASDAQ 100?
  • Is Eli Lilly and Company in the Dow Jones?
  • When was Eli Lilly and Company's last earnings report?
  • When does Eli Lilly and Company report earnings?
  • Should I buy Eli Lilly and Company stock now?

What is the ticker symbol for Eli Lilly and Company?

The ticker symbol for Eli Lilly and Company is NYSE:LLY

Does Eli Lilly and Company pay dividends?

Yes, Eli Lilly and Company pays dividends. The last payment was $1.50, with an ex-dividend date on February 14, 2025

What sector is Eli Lilly and Company in?

Eli Lilly and Company is in the Healthcare sector

What industry is Eli Lilly and Company in?

Eli Lilly and Company is in the Drug Manufacturers - General industry

What country is Eli Lilly and Company based in?

Eli Lilly and Company is headquartered in United States

When did Eli Lilly and Company go public?

Eli Lilly and Company's initial public offering (IPO) was on June 1, 1972

Is Eli Lilly and Company in the S&P 500?

Yes, Eli Lilly and Company is included in the S&P 500 index

Is Eli Lilly and Company in the NASDAQ 100?

No, Eli Lilly and Company is not included in the NASDAQ 100 index

Is Eli Lilly and Company in the Dow Jones?

No, Eli Lilly and Company is not included in the Dow Jones index

When was Eli Lilly and Company's last earnings report?

Eli Lilly and Company's most recent earnings report was on Feb 6, 2025

When does Eli Lilly and Company report earnings?

The next expected earnings date for Eli Lilly and Company is May 1, 2025

Should I buy Eli Lilly and Company stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page